Eric Lefkofsky is a lettered man. He is an alumnus of the University of Michigan. He attained his Juris Doctor from the Michigan University School of Law. Lefkofsky is married to Liz with whom he coordinates in the majority of his projects. He has a passion for getting the antidote or cure for Cancer. Lefkofsky has put numerous measures in place to ensure that his dream materializes. Lefkofsky co-founded Tempus which is a technology company that is mandated with the development of the software of the operating system that is a boon is battling cancer. Lefkofsky partnered with other individuals and came up with Lightbank Company which is a venture that is involved in disruptive technologies.
Lefkofsky co-founded Uptake Technologies which is charged with undertaking predictive analytics for the leading industries in the globe such as Mediaocean, ECHO Global Logistics, and Inner Workings Lefkofsky initiated the Lefkofsky Family Foundation which charitably helps in advancing the high-impact initiatives by spreading love in the respective communities. Lefkofky is a Chairman of the Board of Trustee of the Steppenwolf Theatre of Chicago. Lefkofky is an adjunct professor attached to Chicago University. Lefkofsky has authored Accelerated Disruption.
The milestones undertaken by Eric Lefkofsky in the development of the operating system software that helps in cancer screening has exacerbated the discovery of noble concepts that help fill the missing links as to what causes cancer. Tempus has become a vital company that has taken a critical role of delving deep into the research realms in order to shed light on the causative elements of lung cancer. The research conducted by Dr. Yafang Li on the gene-smoking links brought a good deal of insight into the lung cancer case. The universal notion that only tobacco smokers are more likely to contract lung cancer was superimposed since tobacco nicotine serves as the prerequisite to lung cancer etiology.
There were three genes that were discovered to be the predisposing factor to the acquisition of lung cancer. Two polymorphs of single-nucleotides and one squamous cell lung cancer were established. They served as the lung cancer biomarkers that could be used for screening and intervention. The study was limited to the Caucasian population based on the smoking habits of individuals. The phenotype and genotype data were utilized in the analysis. The information obtained helps in classifying lung cancer according to the smoking habits. The team is aiming at expanding their test to other ethnic setups. The strategies put in place are bound to contribute monumentally in the struggle to combat cancer.